Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tirta Mahakam Resources Tbk (TIRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Tirta Mahakam Resources Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tirta Mahakam Resources Tbk trades at Rp590 (market cap 657.65B, 520K 24h volume). The key difference: Tirta Mahakam Resources Tbk is far larger — about 6.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TIRT | |
|---|---|---|
Market Cap | 104.4B | 657.65B |
Volume | — | 520K |
Lot | — | 5.2K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Tirta Mahakam Resources Tbk
PT Tirta Mahakam Resources Tbk (The Company) was established based on Deed No. 245 dated April 22, 1981 jo. Revision deed No. 14 dated January 11, 1982, both of which were made in front of Notary Kartini Muljadi, SH. The Company started its commercial production in November 1983. The Companys domicilie is in South of Jakarta with its factories in Samarinda, East Kalimantan.
Read more on TIRT →
